Literature DB >> 23312374

Modeling cognitive dysfunction in neurofibromatosis-1.

Kelly A Diggs-Andrews1, David H Gutmann.   

Abstract

Cognitive dysfunction, including significant impairments in learning, behavior, and attention, is found in over 10% of children in the general population. However, in the common inherited cancer predisposition syndrome, neurofibromatosis type 1 (NF1), the prevalence of these cognitive deficits approaches 70%. As a monogenic disorder, NF1 provides a unique genetic tool to identify and dissect mechanistically the molecular and cellular bases underlying cognitive dysfunction. In this review, we discuss Nf1 fly and mouse systems that mimic many of the cognitive abnormalities seen in children with NF1. Further, we describe discoveries from these models that have uncovered defects in the regulation of Ras activity, cAMP generation, and dopamine homeostasis as key mechanisms important for cognitive dysfunction in children with NF1.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312374      PMCID: PMC3622809          DOI: 10.1016/j.tins.2012.12.002

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  115 in total

1.  The MAPK cascade is required for mammalian associative learning.

Authors:  C M Atkins; J C Selcher; J J Petraitis; J M Trzaskos; J D Sweatt
Journal:  Nat Neurosci       Date:  1998-11       Impact factor: 24.884

Review 2.  Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force.

Authors:  K N North; V Riccardi; C Samango-Sprouse; R Ferner; B Moore; E Legius; N Ratner; M B Denckla
Journal:  Neurology       Date:  1997-04       Impact factor: 9.910

3.  Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.

Authors:  H Xu; D H Gutmann
Journal:  Brain Res       Date:  1997-06-06       Impact factor: 3.252

4.  Spatial memory impairment induced by lesion of the mesohippocampal dopaminergic system in the rat.

Authors:  A Gasbarri; A Sulli; R Innocenzi; C Pacitti; J D Brioni
Journal:  Neuroscience       Date:  1996-10       Impact factor: 3.590

5.  A mouse model for the learning and memory deficits associated with neurofibromatosis type I.

Authors:  A J Silva; P W Frankland; Z Marowitz; E Friedman; G S Laszlo; D Cioffi; T Jacks; R Bourtchuladze; G Lazlo
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

6.  Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.

Authors:  M-J Descheemaeker; P Ghesquière; H Symons; J P Fryns; E Legius
Journal:  J Intellect Disabil Res       Date:  2005-01

7.  Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides.

Authors:  H F Guo; I The; F Hannan; A Bernards; Y Zhong
Journal:  Science       Date:  1997-05-02       Impact factor: 47.728

8.  Rescue of a Drosophila NF1 mutant phenotype by protein kinase A.

Authors:  I The; G E Hannigan; G S Cowley; S Reginald; Y Zhong; J F Gusella; I K Hariharan; A Bernards
Journal:  Science       Date:  1997-05-02       Impact factor: 47.728

Review 9.  Nf1 gene targeting: toward models and mechanisms.

Authors:  K Cichowski; T S Shih; T Jacks
Journal:  Semin Cancer Biol       Date:  1996-10       Impact factor: 15.707

10.  Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein (MAP) kinase activation in hematopoietic cells.

Authors:  Atsushi Nonami; Reiko Kato; Koji Taniguchi; Daigo Yoshiga; Takaharu Taketomi; Satoru Fukuyama; Mine Harada; Atsuo Sasaki; Akihiko Yoshimura
Journal:  J Biol Chem       Date:  2004-09-30       Impact factor: 5.157

View more
  37 in total

1.  Risky Decision Making in Neurofibromatosis Type 1: An Exploratory Study.

Authors:  Rachel K Jonas; EunJi Roh; Caroline A Montojo; Laura A Pacheco; Tena Rosser; Alcino J Silva; Carrie E Bearden
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-03

2.  Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.

Authors:  Thijs van der Vaart; André B Rietman; Ellen Plasschaert; Eric Legius; Ype Elgersma; Henriëtte A Moll
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

3.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

4.  Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons.

Authors:  Melissa N Hinman; Alok Sharma; Guangbin Luo; Hua Lou
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

5.  Neurofibromatosis type 1 alternative splicing is a key regulator of Ras/ERK signaling and learning behaviors in mice.

Authors:  Hieu T Nguyen; Melissa N Hinman; Xuan Guo; Alok Sharma; Hiroyuki Arakawa; Guangbin Luo; Hua Lou
Journal:  Hum Mol Genet       Date:  2017-10-01       Impact factor: 6.150

6.  Autism spectrum disorder profile in neurofibromatosis type I.

Authors:  Shruti Garg; Ellen Plasschaert; Mie-Jef Descheemaeker; Susan Huson; Martine Borghgraef; Annick Vogels; D Gareth Evans; Eric Legius; Jonathan Green
Journal:  J Autism Dev Disord       Date:  2015-06

7.  Proposing the use of dental pulp stem cells as a suitable biological model of neurofibromatosis type 1.

Authors:  Paula Nascimento Almeida; Gustavo Torres Souza; Camila Maurmann de Souza; Rafaella Souza Salomão de Zanette; Claudinéia Pereira Maranduba; João Vitor Paes Rettore; Marcelo Oliveira de Santos; Antônio Márcio Resende do Carmo; Carlos Magno Costa da Maranduba; Fernando Sá de Silva
Journal:  Childs Nerv Syst       Date:  2014-12-06       Impact factor: 1.475

Review 8.  Dopaminergic dysfunction in neurodevelopmental disorders: recent advances and synergistic technologies to aid basic research.

Authors:  J Elliott Robinson; Viviana Gradinaru
Journal:  Curr Opin Neurobiol       Date:  2017-08-30       Impact factor: 6.627

9.  Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.

Authors:  L I Petrella; Y Cai; J V Sereno; S I Gonçalves; A J Silva; M Castelo-Branco
Journal:  Genes Brain Behav       Date:  2016-07-05       Impact factor: 3.449

10.  Neurofibromatosis 1-associated panhypopituitarism presenting as hypoglycaemic seizures and stroke-like symptoms.

Authors:  Waqar Waheed; Muriel H Nathan; Gilman B Allen; Neil M Borden; M Ali Babi; Rup Tandan
Journal:  BMJ Case Rep       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.